Skip to main content
U.S. flag

An official website of the United States government

New Audit Announcements


Audit Initiated of NHTSA’s National Drug Control Program Activities

Requested By
Project ID
File Attachment
In September 2021, the Office of National Drug Control Policy issued its National Drug Control Program Agency Compliance Reviews Circular (the Circular). The Circular requires agencies to annually submit two reports on National Drug Control Program (NDCP) activities and the Office of Inspector General to periodically perform an attestation review of these reports. The National Highway Traffic Safety Administration (NHTSA) requested exemptions from our review for fiscal years 2021, 2022, and 2023, which is permitted since its prior year drug-related obligations were less than $50 million. Our last review was conducted for fiscal year 2019, where we identified NHTSA had errors and omissions in its reporting. Given the length of time since our last review and the issues it identified, we are initiating a performance audit of NHTSA’s internal controls over NDCP reporting. Our objective is to assess NHTSA’s internal controls over its NDCP activity.